aTyr Pharma, Inc. Profile Avatar - Palmy Investing

aTyr Pharma, Inc.

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is…

Biotechnology
US, San Diego [HQ]

Lobbying Analysis

aTyr Pharma, Inc. has no lobbying expenses in our database.

History

Download
FY Quarter Expense For Lobby Disclosure LDA Reference
No data
End of LIFE's Analysis
CIK: 1339970 CUSIP: 002120202 ISIN: US0021202025 LEI: - UEI: -
Secondary Listings
LIFE has no secondary listings inside our databases.